UPDATE : Friday, August 7, 2020
상단여백
FDA OKs resumption of phase-3 Invossa trial in US
Kolon Life Science said the U.S. Food and Drug Administration has allowed t...
by Jeong Sae-im  |  2020-04-13 11:58
라인
Samsung signs contract with Vir to make COVID-19 treatment
Samsung Biologics said Friday that it has signed a letter of intent with Vi...
by Shim Hyun-tai  |  2020-04-10 18:07
라인
No Korean firms have entered trials to test COVID-19 drug candidates
Korean pharmaceutical and biotech companies have jumped in developing treat...
by Jeong Sae-im  |  2020-04-08 16:15
라인
Samsung Biologics signs CDO contract with PharmAbcine
Samsung Biologics said Monday that it has signed a contract developing orga...
by Shim Hyun-tai  |  2020-04-06 18:00
라인
AbClon draws many new human antibodies to fight COVID-19
AbClon, a company specializing in developing antibodies, said Monday that i...
by Shim Hyun-tai  |  2020-03-30 17:47
라인
ImmuneMed under fire for inflating drug’s effect against COVID-19
ImmuneMed, a local biotech firm, has come under criticism for exaggerating ...
by Jeong Sae-im  |  2020-03-27 11:49
라인
Warrant sought to arrest Medytox CEO for illegally making, selling Meditoxin
Prosecutors have requested a court to issue an arrest warrant for Medytox C...
by Jeong Sae-im  |  2020-03-25 14:09
라인
Will next-generation COVID-19 tests replace standard PCR checks?
Biotech companies are chasing new diagnostics to detect the new coronavirus...
by Jeong Sae-im  |  2020-03-25 11:40
라인
KoBioLabs' allergic immune disease treatment enters global clinical trial
KoBioLabs, a company specializing in the microbiome, said Monday that it ha...
by Shim Hyun-tai  |  2020-03-23 16:03
라인
Samsung Bioepis’ biosimilar breast cancer treatment scores FDA’s nod
Samsung Bioepis said Friday that the U.S. Food and Drug Administration has ...
by Lee Han-soo  |  2020-03-20 16:52
라인
Samsung Biologics makes CDO partnership with Taiwanese bio-venture
Samsung Biologics said that it has entered into a contract developing organ...
by Lee Han-soo  |  2020-03-17 17:31
라인
Celltrion Healthcare launches anticancer biosimilar Herzuma in US
Celltrion Healthcare said Tuesday that the company has launched its antican...
by Lee Han-soo  |  2020-03-17 16:21
라인
‘Celltrion to invest ₩20 billion to develop COVID-19 cure in 6 months’
Celltrion said that it would start clinical trials on humans to come up wit...
by Lee Han-soo  |  2020-03-13 17:38
라인
SK Bioscience threatens MSD's sway over shingles vaccine market
SK Bioscience's shingles vaccine Skyzoster, launched only two years ago...
by Lee Han-soo  |  2020-03-12 17:05
라인
Bridge Biotherapeutics, Atomwise to develop new drugs using AI
Bridge Biotherapeutics said that it would partner up with Atomwise, a U.S. ...
by Lee Han-soo  |  2020-03-10 12:26
라인
Celltrion applies for approval of new Humira biosimilar to EMA
Celltrion said Monday that it has completed the application of its CT-P17, ...
by Shim Hyun-tai  |  2020-03-09 16:40
라인
Celltrion Healthcare’s 2019 sales top ₩1 trillion
Celltrion Healthcare said that it registered 1 trillion won ($840.6 million...
by Lee Han-soo  |  2020-03-06 17:31
라인
Samsung BioLogics, STCube to develop immunotherapies
Samsung BioLogics said that it has signed a contract development organizati...
by Lee Han-soo  |  2020-03-03 16:18
라인
Celltrion Healthcare presents Remsima SC in UK
Celltrion Healthcare, the distribution and marketing unit of Korea's bi...
by Lee Han-soo  |  2020-03-02 17:42
라인
HLB seeks new pipelines by taking over US biotech firm
HLB, a Kosdaq-listed firm, said it would seek to secure new pipelines other...
by Jeong Sae-im  |  2020-02-21 15:42
여백
여백
여백
Back to Top